Check out this answer from Consensus:
Lowering A1c levels involves a combination of medication, lifestyle interventions, personalized targets, and regular monitoring. By understanding the factors that influence A1c and implementing these strategies, individuals with diabetes can better manage their condition and reduce the risk of complications.
Lowering A1c levels is crucial for managing diabetes and reducing the risk of complications. A1c, or glycated hemoglobin, reflects average blood glucose levels over the past two to three months. Here are several strategies to help lower your A1c levels effectively.
1. Use of Oral Antidiabetic Agents
Oral antidiabetic (OAD) agents are commonly prescribed to help manage blood glucose levels. Studies have shown that most OAD agents can lower A1c levels by 0.5-1.25%, with thiazolidinediones and sulfonylureas achieving reductions of approximately 1.0-1.25%1. The greatest benefit is typically observed within the first 4 to 6 months of therapy. It’s important to note that the initial A1c level can influence the degree of reduction, with higher baseline levels predicting a greater decrease1.
2. Digital Delivery of Lifestyle Interventions
Digital health interventions offer a convenient and effective way to manage diabetes. A systematic review found that digital delivery of lifestyle interventions is associated with decreased A1c levels, comparable to traditional standard care approaches2. These interventions can include online coaching, mobile apps, and telehealth services, which provide support for diet, exercise, and medication adherence.
3. Personalized A1c Targets
Personalizing A1c targets can maximize benefits while minimizing risks. The American College of Physicians (ACP) suggests that A1c targets should be individualized based on patient characteristics, such as age, comorbidities, and life expectancy4. For most patients, an A1c target between 7-8% is recommended, while more relaxed targets may be appropriate for older adults or those with significant comorbid conditions4.
4. Intensive Glycemic Control
Achieving an A1c level of less than 6.0% may reduce the risk of major adverse cardiovascular events (MACE) in people with type 2 diabetes. Bayesian analysis of the ACCORDION and VADT-15 trials suggests that intensive glycemic control could result in a moderate risk reduction in cardiovascular events3. However, this approach should be balanced against the potential risks of hypoglycemia and other adverse effects.
5. Monitoring and Adjusting Treatment
Regular monitoring of A1c levels and adjusting treatment plans accordingly is essential. For patients with diabetes undergoing hemodialysis, maintaining A1c levels within a specific range (7-7.9%) is associated with lower mortality rates5. This highlights the importance of tailoring treatment strategies to individual patient needs and conditions.
6. Understanding the Relationship Between Blood Glucose and A1c
A1c levels provide an overview of blood glucose control over time, but they may not reflect daily fluctuations. A kinetic model of A1c formation and removal shows that recent changes in blood glucose levels have a more significant impact on A1c than older fluctuations6. This underscores the importance of consistent blood glucose management to achieve desired A1c levels.